Hemogenyx Pharmaceuticals (UK) Price History
HEMO Stock | 343.40 20.90 6.48% |
Below is the normalized historical share price chart for Hemogenyx Pharmaceuticals PLC extending back to November 09, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Hemogenyx Pharmaceuticals stands at 343.40, as last reported on the 22nd of December, with the highest price reaching 343.40 and the lowest price hitting 310.00 during the day.
If you're considering investing in Hemogenyx Stock, it is important to understand the factors that can impact its price. Hemogenyx Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.0632, which attests that the entity had a -0.0632% return per unit of risk over the last 3 months. Hemogenyx Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Hemogenyx Pharmaceuticals' Risk Adjusted Performance of (0.04), market risk adjusted performance of 0.4359, and Standard Deviation of 8.04 to validate the risk estimate we provide.
At this time, Hemogenyx Pharmaceuticals' Common Stock Shares Outstanding is comparatively stable compared to the past year. Common Stock is likely to gain to about 12.3 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 2.9 M in 2024. . Hemogenyx Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 555.0695 | 50 Day MA 473.294 | Beta 3.256 |
Hemogenyx |
Sharpe Ratio = -0.0632
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | HEMO |
Estimated Market Risk
8.04 actual daily | 71 71% of assets are less volatile |
Expected Return
-0.51 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Hemogenyx Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hemogenyx Pharmaceuticals by adding Hemogenyx Pharmaceuticals to a well-diversified portfolio.
Price Book 3.9279 | Book Value 0.002 | Enterprise Value 13.2 M | Enterprise Value Ebitda (3.62) | Shares Float 1.2 B |
Hemogenyx Pharmaceuticals Stock Price History Chart
There are several ways to analyze Hemogenyx Stock price data. The simplest method is using a basic Hemogenyx candlestick price chart, which shows Hemogenyx Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 30, 2024 | 646.0 |
Lowest Price | December 18, 2024 | 320.0 |
Hemogenyx Pharmaceuticals December 22, 2024 Stock Price Synopsis
Various analyses of Hemogenyx Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Hemogenyx Stock. It can be used to describe the percentage change in the price of Hemogenyx Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Hemogenyx Stock.Hemogenyx Pharmaceuticals Price Rate Of Daily Change | 1.06 | |
Hemogenyx Pharmaceuticals Price Daily Balance Of Power | 0.63 | |
Hemogenyx Pharmaceuticals Price Action Indicator | 27.15 |
Hemogenyx Pharmaceuticals December 22, 2024 Stock Price Analysis
Hemogenyx Stock Price History Data
The price series of Hemogenyx Pharmaceuticals for the period between Mon, Sep 23, 2024 and Sun, Dec 22, 2024 has a statistical range of 386.0 with a coefficient of variation of 17.15. Under current investment horizon, the daily prices are spread out with arithmetic mean of 503.48. The median price for the last 90 days is 517.2. The company completed 1:400 stock split on 13th of December 2024.Open | High | Low | Close | Volume | ||
12/22/2024 | 335.00 | 343.40 | 310.00 | 343.40 | ||
12/20/2024 | 335.00 | 343.40 | 310.00 | 343.40 | 17,825 | |
12/19/2024 | 335.00 | 335.00 | 300.00 | 322.50 | 33,558 | |
12/18/2024 | 335.00 | 335.00 | 320.00 | 320.00 | 11,406 | |
12/17/2024 | 380.00 | 380.00 | 275.00 | 350.00 | 137,706 | |
12/16/2024 | 420.00 | 420.00 | 350.00 | 378.00 | 37,869 | |
12/13/2024 | 400.00 | 420.00 | 400.00 | 420.00 | 9,040 | |
12/12/2024 | 410.40 | 460.00 | 360.80 | 430.00 | 3,675,051 | |
12/11/2024 | 380.00 | 440.00 | 360.80 | 410.00 | 9,783,042 | |
12/10/2024 | 420.80 | 499.20 | 384.00 | 409.60 | 5,690,503 | |
12/09/2024 | 412.80 | 471.20 | 380.00 | 445.60 | 7,073,259 | |
12/06/2024 | 464.00 | 550.00 | 420.32 | 440.00 | 11,206,666 | |
12/05/2024 | 472.00 | 500.00 | 440.80 | 464.40 | 3,733,935 | |
12/04/2024 | 479.20 | 500.00 | 440.80 | 464.40 | 4,172,561 | |
12/03/2024 | 460.00 | 480.00 | 400.80 | 464.00 | 3,823,472 | |
12/02/2024 | 460.00 | 480.00 | 400.80 | 430.40 | 3,951,369 | |
11/29/2024 | 460.80 | 500.00 | 420.80 | 450.40 | 9,152,409 | |
11/28/2024 | 432.00 | 500.00 | 400.80 | 470.00 | 7,821,509 | |
11/27/2024 | 388.00 | 439.20 | 340.40 | 428.00 | 20,835,767 | |
11/26/2024 | 388.00 | 439.20 | 348.00 | 410.80 | 15,376,176 | |
11/25/2024 | 440.80 | 520.00 | 334.08 | 372.40 | 63,456,156 | |
11/22/2024 | 700.00 | 780.00 | 351.08 | 480.00 | 102,869,447 | |
11/21/2024 | 540.80 | 639.20 | 540.80 | 610.00 | 3,944,953 | |
11/20/2024 | 600.00 | 640.00 | 540.80 | 574.00 | 10,093,154 | |
11/19/2024 | 500.80 | 680.00 | 500.80 | 609.60 | 30,124,522 | |
11/18/2024 | 499.20 | 556.00 | 454.24 | 544.00 | 19,248,783 | |
11/15/2024 | 400.80 | 499.20 | 400.80 | 480.00 | 16,359,418 | |
11/14/2024 | 428.80 | 459.20 | 400.00 | 419.60 | 5,799,607 | |
11/13/2024 | 428.80 | 469.04 | 428.80 | 464.40 | 7,841,493 | |
11/12/2024 | 500.00 | 500.00 | 420.80 | 444.00 | 12,095,361 | |
11/11/2024 | 480.00 | 480.00 | 400.00 | 464.00 | 79,623,217 | |
11/08/2024 | 480.80 | 536.00 | 480.80 | 506.00 | 8,406,525 | |
11/07/2024 | 480.00 | 579.20 | 480.00 | 516.80 | 7,689,066 | |
11/06/2024 | 520.00 | 579.20 | 500.80 | 518.00 | 2,720,856 | |
11/05/2024 | 500.80 | 559.20 | 500.80 | 540.00 | 3,517,718 | |
11/04/2024 | 520.80 | 579.20 | 503.72 | 530.00 | 1,751,875 | |
11/01/2024 | 520.80 | 559.20 | 520.80 | 530.00 | 2,134,555 | |
10/31/2024 | 520.80 | 559.20 | 520.80 | 538.00 | 1,167,915 | |
10/30/2024 | 540.80 | 635.04 | 520.80 | 556.00 | 7,592,137 | |
10/29/2024 | 520.00 | 567.20 | 520.00 | 530.40 | 6,449,158 | |
10/28/2024 | 620.00 | 632.80 | 520.80 | 540.00 | 11,910,971 | |
10/25/2024 | 536.00 | 605.36 | 520.80 | 596.00 | 7,951,714 | |
10/24/2024 | 480.00 | 535.64 | 440.80 | 524.80 | 7,438,331 | |
10/23/2024 | 559.20 | 560.00 | 476.00 | 476.00 | 9,236,740 | |
10/22/2024 | 540.00 | 599.20 | 529.60 | 529.60 | 4,781,293 | |
10/21/2024 | 580.00 | 620.00 | 520.80 | 553.60 | 14,804,188 | |
10/18/2024 | 459.20 | 640.00 | 432.80 | 564.40 | 46,485,912 | |
10/17/2024 | 440.80 | 507.40 | 436.16 | 445.60 | 5,535,996 | |
10/16/2024 | 471.20 | 495.20 | 445.52 | 450.00 | 14,803,242 | |
10/15/2024 | 479.20 | 479.20 | 440.00 | 466.00 | 12,930,685 | |
10/14/2024 | 496.80 | 537.08 | 448.00 | 464.00 | 27,312,073 | |
10/11/2024 | 539.20 | 539.20 | 495.48 | 519.60 | 2,056,855 | |
10/10/2024 | 539.20 | 539.20 | 498.40 | 526.00 | 5,035,205 | |
10/09/2024 | 539.20 | 539.20 | 480.80 | 520.00 | 5,014,256 | |
10/08/2024 | 539.20 | 539.20 | 491.20 | 517.20 | 5,070,293 | |
10/07/2024 | 580.00 | 580.40 | 508.32 | 526.40 | 16,149,828 | |
10/04/2024 | 600.00 | 656.20 | 580.00 | 591.60 | 5,361,199 | |
10/03/2024 | 600.00 | 679.20 | 580.80 | 593.60 | 16,171,903 | |
10/02/2024 | 628.00 | 1,200 | 600.80 | 629.60 | 44,890,963 | |
10/01/2024 | 679.20 | 679.20 | 620.80 | 642.00 | 2,005,556 | |
09/30/2024 | 680.00 | 680.00 | 620.80 | 646.00 | 4,653,911 |
About Hemogenyx Pharmaceuticals Stock history
Hemogenyx Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Hemogenyx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Hemogenyx Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Hemogenyx Pharmaceuticals stock prices may prove useful in developing a viable investing in Hemogenyx Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 1.1 B | 1.2 B | |
Net Loss | -4.6 M | -4.4 M |
Hemogenyx Pharmaceuticals Quarterly Net Working Capital |
|
Hemogenyx Pharmaceuticals Stock Technical Analysis
Hemogenyx Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
All Next | Launch Module |
Hemogenyx Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Hemogenyx Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Hemogenyx Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Hemogenyx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.48) | |||
Total Risk Alpha | (0.73) | |||
Treynor Ratio | 0.4259 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Hemogenyx Stock Analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.